|
Volumn 21, Issue 1, 2010, Pages 63-68
|
Rapid improvement in renal function in patients with multiple myeloma and renal failure treated with bortezomib.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
CREATININE;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
AGED;
ARTICLE;
BLOOD;
CONVALESCENCE;
DRUG EFFECT;
FEMALE;
HUMAN;
KIDNEY;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PATHOPHYSIOLOGY;
TIME;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL MARKERS;
BORONIC ACIDS;
CREATININE;
FEMALE;
HUMANS;
KIDNEY;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PROTEASE INHIBITORS;
PYRAZINES;
RECOVERY OF FUNCTION;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 77949324943
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|